A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA

PHASE3CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

July 18, 2023

Study Completion Date

July 18, 2023

Conditions

Excessive Daytime Sleepiness

Interventions

DRUG

Pitolisant

Wakix tablet

DRUG

Placebo oral tablet

Matching placebo tablets will be provided for each strength of active pitolisant film-coated tablets.

Trial Locations (1)

Tsinghua Changgung Hospital, Beijing